Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.35    -0.10 (-0.61%)
Bid:
16.30
Ask:
16.45
Spread: 0.15 (0.92%)
Market Cap: £131.05m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Board Appointment

7 Dec 2010 07:00

RNS Number : 4730X
Allocate Software PLC
07 December 2010
Β 

ο»Ώ

7 December 2010

Β 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

Β 

Β 

Board Appointment

Β 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, announces that it has appointed Richard King as a Non-Executive Director, who will join the board with effect from 1 January 2011.

Β 

Mr King (54) has worked with Ernst & Young since 1975, where he is currently Deputy Managing Partner, Ernst & Young, UK and Ireland with specific responsibility for D&I, Service Quality to major accounts and the partner alumni programme. In this role Mr King led the successful integration of the UK and Ireland businesses to create a Β£1 billion practice. Prior to this he had responsibility for the Ernst & Young offices outside London and in Ireland, with 4,000 employees in 28 offices.

Β 

He is also the Chairman of The Willow Foundation, a national charity established by Arsenal legend, Bob Wilson, which provides special days for seriously ill 16 to 40 year olds.

Β 

Terry Osborne, Allocate Software plc's Chairman, commented: "I am delighted to welcome Richard to the Board of Directors of Allocate Software plc. Richard is a high calibre individual with significant success and experience in the areas of finance, governance and managing change in a large, growing and highly regarded organization. His appointment will further strengthen our Board as Allocate becomes a larger and more significant player in its markets, both home and abroad. "

Β 

Richard King commented: "I am delighted to be joining the Board of Allocate Software. We have a very strong management team in place who have already created a market leading business. I am looking forward to working with the team to help them achieve their exciting plans."

Details of Mr King's current and previous directorships and partnerships in the past five years are set out below.

Β 

Current directorships and partnerships:

Ernst & Young LLP

Ernst & Young Europe LLP

EY (NEMIA) Limited

The Willow Foundation

Previous directorships and partnerships:

Ernst & Young EMEIA Limited

Park Street Nominees Limited

Β 

Β 

There is no further information in connection with the appointment of Mr King to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

Β 

Β 

Β 

Enquiries:

Β 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Β 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Richard Thomas

Corporate Broking - James Black

Β 

Tel: +44 (0) 20 7260 1000

Hansard Communications

Justine James

Β 

Tel: +44 (0) 20 7245 1100

+44 (0) 7525 324 431

Β 

Β 

About Allocate Software plc

Β 

Allocate Software plc is the leading supplier of workforce and compliance optimisation solutions for world-wide organisations with large, multi-skilled workforces. Using Allocate Software's workforce and governance optimisation software, organisations can deploy the right people with the right skills, to the right place at the right time, allowing organisations to match operational demands with workforce supply ensuring efficiency, safety and compliance whilst reducing costs.

Headquartered in London with regional offices in the UK, Sweden, USA, Australia, Malaysia, Allocate Software provide services and support to an international customer base in key vertical sectors including: Healthcare, Defence, Maritime/Offshore, Government and Education.Β 

Allocate Software plc is quoted on the London Stock Exchange (AIM: ALL). For further information please visitΒ www.allocatesoftware.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOALFFSFFELRIII
Date   Source Headline
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results
4th Sep 20238:45 amRNSConference Attendance
30th Aug 20237:00 amRNSIssue of Equity - ESOP Options
22nd Aug 20237:00 amRNSIssue of Equity - Exercise of ESOP Options
17th Aug 20237:00 amRNSPartner Commits to Ewoyaa Development Funding
15th Aug 20237:00 amRNSMOU Signed for By-product Feldspar Study
10th Aug 20239:14 amRNSPCA Dealings
9th Aug 20239:30 amRNSDirector/PDMR Dealings
8th Aug 20237:00 amRNSResource and Exploration Drilling Results
7th Aug 20233:13 pmRNSStatement re Media Speculation
31st Jul 20237:00 amRNSQuarterly Activities and Cash Flow Report
19th Jul 20237:00 amRNSConference Attendance
13th Jul 20237:00 amRNSAppointment of Flotation Scoping Study Partner
30th Jun 20237:00 amRNSInvestor Presentation
29th Jun 20238:21 amRNSEwoyaa Definitive Feasibility Study
29th Jun 20237:17 amRNSEwoyaa Definitive Feasibility Study
23rd Jun 202311:00 amRNSBoard Appointments
20th Jun 20237:00 amRNSInitial Infill Drilling Results
16th Jun 20237:00 amRNSConference Attendance
13th Jun 20237:00 amRNSCorporate Update - Resignation of Director
1st Jun 20237:00 amRNSBoard Changes
26th May 20237:00 amRNSDTC Eligibility for OTCQX Electronic Trading
17th May 20237:00 amRNSConference Attendance
16th May 20237:00 amRNSAppointment of Chief Executive Officer
4th May 20237:00 amRNSConference Attendance
28th Apr 20237:00 amRNSQuarterly Activities and Cash Flow Report
26th Apr 20237:00 amRNSInternational Lithium Association Membership
19th Apr 20237:00 amRNSInfill Drilling and Passive Seismic Survey
6th Apr 20237:00 amRNSIssue of Equity – Exercise of ESOP Options
31st Mar 20237:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.